Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-2313.27%
operating margin TTM
-2437.49%
revenue TTM
2.96 Million
revenue per share TTM
0.08$
valuation ratios | |
|---|---|
| pe ratio | -1.73 |
| peg ratio | 0.35 |
| price to book ratio | 3.21 |
| price to sales ratio | 41.75 |
| enterprise value multiple | -2.03 |
| price fair value | 3.21 |
profitability ratios | |
|---|---|
| gross profit margin | 92.27% |
| operating profit margin | -2437.49% |
| pretax profit margin | -2313.27% |
| net profit margin | -2313.27% |
| return on assets | -80.11% |
| return on equity | -135.24% |
| return on capital employed | -107.23% |
liquidity ratio | |
|---|---|
| current ratio | 4.27 |
| quick ratio | 4.26 |
| cash ratio | 1.37 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 309.53 |
| operating cycle | 322.26 |
| days of payables outstanding | 9,185.83 |
| cash conversion cycle | -8,863.57 |
| receivables turnover | 28.67 |
| payables turnover | 0.04 |
| inventory turnover | 1.18 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.05 |
| total debt to capitalization | 0.06 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -22.60 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.38 |
| cash per share | 1.81 |
| operating cash flow per share | -1.37 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -22.60 |
| short term coverage ratios | -91.92 |
| capital expenditure coverage ratio | -174.94 |
Frequently Asked Questions
When was the last time Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) reported earnings?
Orchestra BioMed Holdings, Inc. (OBIO) published its most recent earnings results on 12-11-2024.
What is Orchestra BioMed Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)'s trailing twelve months ROE is -135.24%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Orchestra BioMed Holdings, Inc. (OBIO) currently has a ROA of -80.11%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OBIO's net profit margin stand at?
OBIO reported a profit margin of -2313.27% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OBIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.27 in the most recent quarter. The quick ratio stood at 4.26, with a Debt/Eq ratio of 0.07.